News
-
UNC Scientists visualize competition between healthy and dysfunctional platelets for space in an injured blood vessel
A UNC School of Medicine research team, led by Dr. Wolfgang Bergmeier, studied why platelet transfusion therapy does not work for some patients with platelet function disorders. Using real-time imaging allows researchers to understand the interaction between healthy and dysfunctional platelets, which is critical to improve the use of platelet therapy.
-
Dr. Weiss is named Principal Investigator for the Phase 2 study focused expanding immunotherapy treatment
Dr. Jared Weiss, associate professor of medicine in the division of hematology and oncology and researcher with UNC Lineberger Cancer Center, will lead a phase two study evaluating a new combination of drugs as a first-line treatment for patients with recurrent or metastatic HPV positive head and neck cancer. This study’s goal is to expand this … Continued
-
UNC Cancer Center receives funding to research new form of cancer care using gene therapy
UNC Lineberger Comprehensive Cancer Center’s Dr. Chad Pecot was awarded $100,000 by the North Carolina Biotechnology Center to research a new treatment that selectively silences mutated KRAS genes, which are commonly associated with cancer. Pecot’s lab is also studying how to deliver the treatment specifically to cancer cells.
-
UNC researchers develop new tool to improve pancreatic cancer treatment options
Researchers at UNC Lineberger Comprehensive Cancer Center created a new method to classify pancreatic tumors, improving personalization of treatment for patients. Using machine learning, the new system can predict individual patient responses to chemotherapy.